Sodium phosphate dibasic is an inorganic salt commonly used in medicine as a phosphate supplement, laxative, and buffering agent. It plays an essential role in maintaining phosphate homeostasis, correcting hypophosphatemia, and facilitating bowel cleansing before diagnostic procedures such as colonoscopy. Its importance extends to intravenous formulations, oral electrolyte solutions, and laboratory preparations, reflecting its versatility in both clinical and industrial settings.
Chemical Structure
Sodium phosphate dibasic is composed of sodium ions (Na⁺) and dibasic phosphate anions (HPO₄²⁻).
- Chemical formula: Na₂HPO₄
- Molecular weight: 141.96 g/mol
- Physical properties: White, crystalline, water-soluble solid
- Structure: Contains two sodium cations bonded ionically to one dibasic phosphate anion. In aqueous solution, it acts as a buffering agent, helping maintain pH levels.

Its ionic nature allows it to participate in electrolyte and acid-base regulation in the body.
Sodium Phosphate Dibasic-Based Medicines List
- Fleet® Phospho-Soda – Oral sodium phosphate for bowel cleansing.
- Sodium Phosphate Dibasic Injection – IV formulation for phosphate supplementation.
- Phos-Na® Tablets – Oral phosphate replacement therapy.
- Bowel Prep Kit Solutions – Combination oral formulations containing dibasic and monobasic sodium phosphate.
- Enemas containing sodium phosphate – Used for constipation relief and pre-procedural bowel prep.
- Electrolyte and fluid replacement solutions – Contains sodium phosphate as a buffer component.
- Buffered IV solutions – Used to maintain pH stability in parenteral medications.
- Laboratory and diagnostic reagents – Although not therapeutic, widely used in standardized formulations.
Mechanism of Action
Sodium phosphate dibasic functions primarily as a phosphate source and osmotic agent:
- As a laxative: Draws water into the intestinal lumen by osmotic action, softening stool and inducing bowel movements.
- As a phosphate supplement: Provides inorganic phosphate, which is critical for cellular energy production, nucleic acid synthesis, and bone mineralization.
- As a buffer: Maintains acid-base homeostasis in oral or intravenous formulations by regulating hydrogen ion concentration.
Its osmotic effect in the gut is particularly utilized for bowel cleansing before endoscopic or radiologic procedures.
Pharmacokinetics
- Absorption: Oral sodium phosphate is partially absorbed in the intestines. IV formulations provide immediate systemic availability.
- Distribution: Phosphate distributes predominantly to extracellular fluid and bone tissue.
- Metabolism: Not metabolized; it participates in normal phosphate metabolism.
- Excretion: Primarily excreted by the kidneys; urinary excretion adjusts to maintain phosphate balance.
- Half-life: Varies depending on renal function; phosphate levels are tightly regulated by renal reabsorption and parathyroid hormone.
Excess phosphate from oral or IV administration can result in transient hyperphosphatemia, especially in patients with renal impairment.
Therapeutic Uses
| Condition | Formulation / Use | Role of Sodium Phosphate Dibasic |
|---|---|---|
| Constipation | Oral / enema | Osmotic laxative effect draws water into the colon |
| Bowel cleansing pre-colonoscopy | Oral solution | Evacuates intestinal contents for optimal visualization |
| Hypophosphatemia | Oral / IV phosphate | Replenishes phosphate to correct deficiency |
| Electrolyte replacement | IV fluid formulations | Maintains phosphate and sodium balance |
| Acid-base balance | Buffered IV or oral solutions | Acts as a buffering agent to stabilize pH |
| Chronic renal insufficiency (adjunct) | Oral phosphate therapy | Prevents hypophosphatemia during dialysis |
| Osteomalacia / rickets | Oral phosphate supplementation | Supports bone mineralization |
| Laboratory and diagnostic use | Oral / IV as reagent | Facilitates standardized osmotic or buffering actions |
Side Effects
Sodium phosphate dibasic is generally well tolerated when used appropriately, but adverse effects can occur, especially with oral bowel prep or high-dose supplementation:
- Common: Nausea, bloating, abdominal cramping, diarrhea.
- Less common: Vomiting, electrolyte disturbances such as mild hyperphosphatemia or hypocalcemia.
- Serious / Rare:
- Acute phosphate nephropathy (kidney injury due to precipitation of calcium-phosphate crystals)
- Severe hyperphosphatemia leading to hypocalcemia, tetany, or arrhythmias
- Fluid overload in susceptible patients (heart failure or renal impairment)
- Electrolyte imbalances, including hypernatremia or hypokalemia
Monitoring of serum phosphate, calcium, and renal function is recommended during high-dose or repeated use.
Drug Interactions
- Calcium supplements or antacids: Can form insoluble calcium-phosphate complexes, reducing absorption.
- Diuretics (loop, thiazide): May exacerbate electrolyte disturbances.
- Magnesium-containing medications: Risk of precipitation in the gut or kidneys.
- Nephrotoxic drugs: Concomitant use may increase risk of phosphate nephropathy.
- Oral tetracyclines: Phosphate may reduce antibiotic absorption due to chelation.
Careful monitoring and timing of doses are recommended to minimize interactions.
Safety Considerations
- Pregnancy: Generally considered safe as a short-term osmotic laxative or phosphate supplement; avoid prolonged high-dose use.
- Lactation: Safe in recommended doses.
- Renal impairment: High risk of phosphate retention and nephropathy; use cautiously or avoid.
- Elderly patients: Increased susceptibility to dehydration, electrolyte imbalances, and kidney injury.
- Administration: Oral bowel prep should be followed with adequate hydration; IV phosphate must be infused slowly to avoid hyperphosphatemia or hypocalcemia.
Regulatory Status
- “Sodium phosphate dibasic” is approved worldwide as a phosphate supplement and laxative.
- Prescription status varies: Oral bowel prep and IV phosphate may require medical supervision, whereas low-dose oral supplementation may be over-the-counter in some regions.
- Included in clinical guidelines for colonoscopy prep, hypophosphatemia management, and electrolyte replacement.
- Monitoring for kidney function and electrolytes is mandated for high-dose or repeated use due to risk of nephropathy.

Conclusion
Sodium phosphate dibasic is a versatile pharmaceutical agent with critical roles in gastroenterology, nephrology, and general medicine. Its dual function as an osmotic laxative and phosphate supplement makes it essential for bowel cleansing, phosphate replacement, and electrolyte management. While generally safe when used correctly, careful attention to renal function, hydration status, and electrolyte balance is necessary to prevent serious complications such as phosphate nephropathy or severe hyperphosphatemia. Its widespread availability and clinical utility make it a cornerstone in both hospital and outpatient settings.










